What are the treatment and management steps for a patient who accidentally took two doses of Cardizem (diltiazem) 240 mg orally?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Diltiazem 240 mg Double Dose Overdose

For a patient who accidentally took two doses of Cardizem (diltiazem) 240 mg orally, immediate monitoring for cardiovascular effects and supportive care are required, with administration of intravenous calcium if significant hypotension or bradycardia develops.

Initial Assessment and Monitoring

  • Immediately establish continuous cardiac monitoring for:

    • Bradycardia
    • Heart block (particularly AV block)
    • Hypotension
    • Signs of cardiac failure
  • Obtain baseline vital signs:

    • Blood pressure (watch for hypotension)
    • Heart rate (watch for bradycardia)
    • Respiratory rate
    • Oxygen saturation
  • Obtain 12-lead ECG to assess for:

    • PR interval prolongation
    • QRS widening
    • Heart blocks
    • Bradyarrhythmias
  • Establish IV access for potential medication administration

Treatment Algorithm

For Asymptomatic Patients (normal vitals, no ECG changes)

  1. Continue cardiac monitoring for at least 6-8 hours
  2. Consider activated charcoal if presentation is within 1-2 hours of ingestion
  3. Maintain IV access
  4. Monitor for delayed toxicity (can occur up to 18 hours post-ingestion) 1

For Symptomatic Patients

Bradycardia Management:

  1. Administer atropine 0.6-1.0 mg IV 2
  2. If no response to atropine, consider:
    • Isoproterenol (cautious administration)
    • Temporary cardiac pacing for persistent bradycardia or high-degree AV block 2, 3

Hypotension Management:

  1. Administer intravenous calcium:
    • 1 g calcium chloride or 3 g calcium gluconate over 5 minutes
    • May repeat every 10-20 minutes as necessary
    • For severe cases, consider calcium gluconate continuous infusion at 2 g per hour 2, 1
  2. If hypotension persists, administer vasopressors:
    • Dopamine or norepinephrine 2

Cardiac Failure Management:

  1. Administer inotropic agents:
    • Isoproterenol, dopamine, or dobutamine
  2. Consider diuretics if signs of pulmonary edema 2

Special Considerations

  • High-dose calcium therapy: Consider aggressive high-dose IV calcium (up to 13.5 g has been reported) particularly if severe bradycardia or asystole develops 1

  • Avoid certain medications:

    • Do not administer additional calcium channel blockers or beta-blockers
    • Avoid medications that may worsen bradycardia or hypotension
  • Monitoring duration: Extended monitoring (24 hours) is recommended due to potential for delayed toxicity, especially with sustained-release formulations 1

  • Gastrointestinal decontamination: Consider activated charcoal if presentation is within 1-2 hours of ingestion 2

Prognosis

Most patients recover from diltiazem overdose with appropriate supportive care. Fatal outcomes are typically associated with multiple drug ingestions rather than isolated diltiazem overdose 2.

Pitfalls to Avoid

  • Underestimating delayed toxicity: Symptoms can worsen 18+ hours after ingestion, particularly with extended-release formulations 1

  • Inadequate calcium dosing: In severe cases, higher doses of calcium than typically used may be necessary 1

  • Premature discontinuation of monitoring: Continue cardiac monitoring for at least 24 hours due to risk of delayed effects

  • Fluid overload: Avoid excessive fluid administration in patients with cardiac dysfunction; vasopressors may be preferable for managing hypotension 4

References

Research

Massive diltiazem overdose.

Annals of emergency medicine, 1986

Guideline

Cardiac Management with Diltiazem

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.